WallStreetZenWallStreetZen

NASDAQ: CELZ
Creative Medical Technology Holdings Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Creative Medical Technology Holdings revenue was $6.00k for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CELZ annual revenue was $11.0k, with 22.2% growth year-over-year.

CELZ past revenue growth

How has CELZ's revenue growth performed historically?

Company
-45.45%
Industry
284.61%
Market
22.91%
CELZ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CELZ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

CELZ revenue history

Current Revenue
$6.0k
Current Earnings
-$6.0M
Current Profit Margin
-99,356.8%

Be the first to know when CELZ announces revenue.

CELZ Revenue History By Year

CELZ Yearly RevenueCELZ RevenueCELZ ChangeCELZ Revenue Growth
2024-12-31$11.00k$2.00k+22.22%
2023-12-31$9.00k-$79.60k-89.84%
2022-12-31$88.60k$846.00+0.96%
2021-12-31$87.75k-$76.75k-46.65%
2020-12-31$164.50k-$1.00k-0.60%
2019-12-31$165.50k$41.10k+33.04%
2018-12-31$124.40k$119.60k+2,491.67%
2017-12-31$4.80kN/AN/A
2016-12-31$0.00N/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00N/AN/A
2013-12-31$0.00N/AN/A
2012-12-31$0.00N/AN/A
2011-12-31$0.00N/AN/A
2010-12-31$0.00N/AN/A
2009-12-31$0.00N/AN/A
2008-12-31$0.00N/AN/A
2007-12-31$0.00N/AN/A
2006-12-31$0.00N/AN/A

1 of 2

Creative Medical Technology Holdings Revenue FAQ

What was CELZ's revenue last quarter?

Creative Medical Technology Holdings (NASDAQ: CELZ) reported Q3 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Creative Medical Technology Holdings's revenue was $0.00.

What was Creative Medical Technology Holdings's revenue in 2024?

Creative Medical Technology Holdings's annual revenue for the twelve months ending Dec 31, 2024 was $11.00 thousand, a 22.22% increase year over year.

How much does Creative Medical Technology Holdings make in a day?

Based on Creative Medical Technology Holdings annual revenue for the past five years, CELZ makes an average of $197.73 per day.

What was Creative Medical Technology Holdings's annual revenue growth in the past year?

As of Q4 2025, Creative Medical Technology Holdings's revenue has grown -45.45% year over year. This is 330.06 percentage points lower than the US Biotechnology industry revenue growth rate of 284.61%. Creative Medical Technology Holdings's revenue in the past year totaled $6.00 thousand.

How much does Creative Medical Technology Holdings make in a year?

Creative Medical Technology Holdings's revenue by year for the past five years is:
  • Creative Medical Technology Holdings's revenue for the twelve months ending Dec 31, 2024 was $11.00 thousand, a 22.22% increase year over year.
  • Creative Medical Technology Holdings's annual revenue for Dec 31, 2023 was $9.00 thousand, a 89.84% decrease from 2022.
  • Creative Medical Technology Holdings's annual revenue for 2022 was $88.60 thousand, a 0.96% increase from 2021.
  • Creative Medical Technology Holdings's annual revenue for 2021 was $87.75 thousand, a 46.65% decrease from 2020.
  • Creative Medical Technology Holdings's annual revenue for 2020 was $164.50 thousand, a 0.6% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.